MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
26.31
+1.04
+4.12%
After Hours: 26.10 -0.21 -0.80% 19:31 12/15 EST
OPEN
25.78
PREV CLOSE
25.27
HIGH
26.50
LOW
25.56
VOLUME
472.90K
TURNOVER
--
52 WEEK HIGH
42.49
52 WEEK LOW
20.39
MARKET CAP
1.21B
P/E (TTM)
11.67
1D
5D
1M
3M
1Y
5Y
1D
Amphastar Pharmaceuticals Director Makes Noteworthy Stock Sale
TipRanks · 4h ago
Director Floyd F. Petersen Reports Disposal of Amphastar Pharmaceuticals Inc. Common Shares
Reuters · 8h ago
Monday's ETF Movers: IHE, BLOK
NASDAQ · 10h ago
Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015
TipRanks · 15h ago
Amphastar reports FDA approval for teriparatide injection
Seeking Alpha · 19h ago
Amphastar announces FDA approval for teriparatide injection
TipRanks · 19h ago
Amphastar Announced FDA Approval for Teriparatide Injection
Benzinga · 19h ago
AMPHASTAR PHARMACEUTICALS INC: FDA APPROVAL FOR TERIPARATIDE INJECTION
Reuters · 19h ago
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.